Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial Tumor
NCT04667793
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Thymic Epithelial Tumor
Interventions
DRUG:
Toripalimab + Chemotherapy
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China